IL103065A - Isolated protein which inhibits collagen induced platelet aggregation, processes for the preparation thereof and a pharmaceutical composition containing the same - Google Patents

Isolated protein which inhibits collagen induced platelet aggregation, processes for the preparation thereof and a pharmaceutical composition containing the same

Info

Publication number
IL103065A
IL103065A IL10306592A IL10306592A IL103065A IL 103065 A IL103065 A IL 103065A IL 10306592 A IL10306592 A IL 10306592A IL 10306592 A IL10306592 A IL 10306592A IL 103065 A IL103065 A IL 103065A
Authority
IL
Israel
Prior art keywords
protein
inhibitor
collagen
dna
sequence
Prior art date
Application number
IL10306592A
Other languages
English (en)
Other versions
IL103065A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to IL11949192A priority Critical patent/IL119491A/xx
Publication of IL103065A0 publication Critical patent/IL103065A0/xx
Priority to IL11949196A priority patent/IL119491A0/xx
Publication of IL103065A publication Critical patent/IL103065A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL10306592A 1991-09-05 1992-09-04 Isolated protein which inhibits collagen induced platelet aggregation, processes for the preparation thereof and a pharmaceutical composition containing the same IL103065A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL11949192A IL119491A (en) 1991-09-05 1992-09-04 cDNA or DNA encoding a protein which inhibits collagen-induced platelet aggregation
IL11949196A IL119491A0 (en) 1991-09-05 1996-10-25 cDNA or DNA which inhibits collagen-induced platelet aggregation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75621191A 1991-09-05 1991-09-05
US81488491A 1991-12-31 1991-12-31
US91438392A 1992-07-17 1992-07-17

Publications (2)

Publication Number Publication Date
IL103065A0 IL103065A0 (en) 1993-02-21
IL103065A true IL103065A (en) 2001-11-25

Family

ID=27419489

Family Applications (4)

Application Number Title Priority Date Filing Date
IL10306592A IL103065A (en) 1991-09-05 1992-09-04 Isolated protein which inhibits collagen induced platelet aggregation, processes for the preparation thereof and a pharmaceutical composition containing the same
IL11949192A IL119491A (en) 1991-09-05 1992-09-04 cDNA or DNA encoding a protein which inhibits collagen-induced platelet aggregation
IL11949296A IL119492A0 (en) 1991-09-05 1996-10-25 Proteins which inhibit collagen-induced platelet aggregation DNA and cDNA coding therefor processes for its production and pharmaceutical compositions containing the same
IL11949196A IL119491A0 (en) 1991-09-05 1996-10-25 cDNA or DNA which inhibits collagen-induced platelet aggregation

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL11949192A IL119491A (en) 1991-09-05 1992-09-04 cDNA or DNA encoding a protein which inhibits collagen-induced platelet aggregation
IL11949296A IL119492A0 (en) 1991-09-05 1996-10-25 Proteins which inhibit collagen-induced platelet aggregation DNA and cDNA coding therefor processes for its production and pharmaceutical compositions containing the same
IL11949196A IL119491A0 (en) 1991-09-05 1996-10-25 cDNA or DNA which inhibits collagen-induced platelet aggregation

Country Status (16)

Country Link
EP (1) EP0530937B1 (hu)
JP (2) JPH07506959A (hu)
KR (1) KR100232683B1 (hu)
AT (1) ATE169674T1 (hu)
AU (1) AU672584B2 (hu)
CA (1) CA2117174A1 (hu)
DE (1) DE69226580T2 (hu)
DK (1) DK0530937T3 (hu)
ES (1) ES2121817T3 (hu)
FI (1) FI112801B (hu)
HU (1) HU218830B (hu)
IL (4) IL103065A (hu)
NO (1) NO314848B1 (hu)
NZ (1) NZ244246A (hu)
RU (1) RU2128705C1 (hu)
WO (1) WO1993005150A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10505502A (ja) * 1994-09-12 1998-06-02 シェーリング アクチェンゲゼルシャフト 修飾されたコラーゲン誘導血小板凝集阻害剤パリジピンの製法
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
JP3837518B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−4蛋白質
JP3837519B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−3蛋白質
AU2003227721A1 (en) * 2003-05-02 2004-11-23 Paion Gmbh Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke
CA2522989A1 (en) * 2003-05-21 2004-12-02 Ares Trading S.A. Method of chromatographic analysis of a protein solution
EP1760092A1 (en) * 2005-08-26 2007-03-07 Applied Research Systems ARS Holding N.V. System for screening cells for high expression of a protein of interest
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
JP5332178B2 (ja) * 2007-11-02 2013-11-06 東洋紡株式会社 多色ルシフェラーゼの検出方法
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
CN109125355B (zh) * 2018-08-03 2022-07-08 昆明医科大学第一附属医院 心脉隆抗血小板及抗血栓药理应用
CN112354570B (zh) * 2019-07-11 2022-02-11 北京理工大学 一种多维微流控电泳芯片及检测装置,检测方法

Also Published As

Publication number Publication date
KR100232683B1 (ko) 1999-12-01
HU9400662D0 (en) 1994-06-28
FI941052A (fi) 1994-03-04
IL119492A0 (en) 1997-01-10
HU218830B (hu) 2000-12-28
NO314848B1 (no) 2003-06-02
HUT70271A (en) 1995-09-28
NO940771D0 (no) 1994-03-04
IL103065A0 (en) 1993-02-21
RU2128705C1 (ru) 1999-04-10
ES2121817T3 (es) 1998-12-16
WO1993005150A1 (en) 1993-03-18
EP0530937B1 (en) 1998-08-12
DK0530937T3 (da) 1999-05-10
IL119491A (en) 2000-11-21
JP2003313199A (ja) 2003-11-06
NZ244246A (en) 1994-03-25
AU672584B2 (en) 1996-10-10
CA2117174A1 (en) 1993-03-18
RU94045930A (ru) 1996-07-20
IL119491A0 (en) 1997-01-10
JPH07506959A (ja) 1995-08-03
AU2502292A (en) 1993-04-05
FI941052A0 (fi) 1994-03-04
NO940771L (no) 1994-03-04
DE69226580T2 (de) 1999-03-04
ATE169674T1 (de) 1998-08-15
DE69226580D1 (de) 1998-09-17
EP0530937A1 (en) 1993-03-10
FI112801B (fi) 2004-01-15

Similar Documents

Publication Publication Date Title
KR100188302B1 (ko) 활성화피브린용해성과항-혈전성단백질
JP3136551B2 (ja) インターロイキン1β前駆体変換酵素をコードするDNA
DK176140B1 (da) Flagermusspyt-plasminogenaktivatorer
AU672584B2 (en) Collagen-induced platelet aggregation inhibitor
Estaller et al. Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150-kDa molecule.
EP1056854A2 (en) Protease-activated receptor 4 and uses thereof
JPH07503849A (ja) プロテアーゼ−耐性トロンボモジュリン・アナログ
RU2186110C2 (ru) Рекомбинантный белок asp-паллидипин, способ его производства и очистки, вектор, штамм, фармацевтическая композиция
US5756454A (en) Collagen-induced platelet aggregation inhibitor
US5589360A (en) Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
AU627475B2 (en) Tissue plasminogen activator analogues having improved activity
KR20010052887A (ko) 안지오스타틴-결합 단백질
CA2150909A1 (en) Clotting inhibitor made from protostomia saliva
WO2001000667A2 (en) Anti-thrombin peptide from anopheles albimanus salivary gland
EP0693925B1 (en) Production of a recombinant factor xa inhibitor of leech hirudo medicinalis
Palladino et al. Expression and characterization of the N-terminal half of antistasin, an anticoagulant protein derived from the leech Haementeria officinalis
CA2176507A1 (en) Endothelin-converting enzyme
EP0468764A1 (en) Method for administering a therapeutic anticoagulant
JP2002125671A (ja) 新規rsbU−1
MXPA02000677A (es) Proteinas inhibidoras.
JPH07316199A (ja) ラットプロテア−ゼインヒビタ−
MXPA00011922A (en) Angiostatin-binding protein
JPH0559099A (ja) ラツトプロテア−ゼインヒビタ−
CA2323936A1 (en) Estrogen receptor

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees